LINC02332

Across TCGA pan-cancer cohorts, LINC02332 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LINC02332’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02332 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02332 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC, THCA, and COAD are the cancer types where LINC02332 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02332 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−1.237	<.001	12	view →
THCA	All	II,III,IV	+0.756	<.001	10	view →
COAD	Male	All	+0.474	<.001	10	view →
KICH	Male	III,IV	−1.582	<.001	8	view →
KIRP	Male	III,IV	−1.034	<.001	8	view →
LUAD	Female	All	+0.807	<.001	8	view →
CHOL	Male	All	+1.011	<.001	5	view →
LUSC	All	All	+0.430	<.001	3	view →
BRCA	All	All	+0.181	.008	2	view →
PRAD	All	All	−0.110	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LINC02332–KIRC

Open the KIRC breakdown →